CLINICAL_TRIALS
trial_result
· 2017-05-24
Clinical Trial Update: Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) [Phase 2]
Summary
Phase 2 pilot trial of zoledronic acid in malignant mesothelioma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-24